July 7, 2015 - The Texas Center for Proton Therapy announced it has selected RayStation from RaySearch Laboratories as its treatment planning software. The 63,000-square-foot facility in the Dallas/Fort Worth area will have capacity to treat more than 100 patients per day in three treatment rooms when it opens in late 2015. It will be the first stand-alone LEED-Certified (Leadership in Energy and Environmental Design) proton therapy center in the United States.
"It is our goal to provide advanced technologies such as robust optimization, PBS [pencil beam scanning], IMPT [intensity modulated proton therapy] and full adaptive therapy, right from the start of clinical operations. We believe that RaySearch has a proven track record that can help us deliver on the promise of developing treatment plans with the best technology available today in proton therapy," said Andrew Lee, M.D., medical director of the center. "We will also utilize the wide area network available at the local Texas Oncology facilities so that we can share information and develop the best plans available for the patients. We can compare conventional photon plans with proton plans and choose the right course of action," he concluded.
Lee joins Texas Center for Proton Therapy following almost 14 years at The University of Texas MD Anderson Cancer Center. He also served as the first and founding director of the Program for Advanced Technology, and as the medical director of the MD Anderson Proton Therapy Center.
The current version of RayStation supports all relevant proton treatment techniques such as uniform scanning, double scattering and PBS/IMPT. It also features unique functionalities like multi-criteria optimization (MCO) for PBS optimization. MCO planning makes it possible to plan in a more interactive and exploratory way where fundamental trade-offs can be made in real time by the dosimetrist and the physician. It can help simplify the planning process while improving the quality of the plans.
The Texas Center for Proton Therapy is a collaboration of Texas Oncology and The U.S. Oncology Network, supported by McKesson Specialty Health and Baylor Health Enterprises, an affiliate of Baylor Health Care System.
For more information: www.raysearchlabs.com
October 01, 2026 
